Barclays Maintains an 'Equalweight' on WebMD Health (WBMD); Sale Speculation Intensifies
Tweet
Share
E-mailGet Alerts WBMD Hot Sheet
Price: $66.48 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on WebMD Health Corp. (NASDAQ: WBMD) price target of $33.00.
Barclays analyst says, "What's new?: The New York Post reported yesterday (see 12/15/11 article, "Private Practice: WebMD close to sealing a deal with PE firms") that WebMD has put itself up for sale and that private equity firms KKR and Providence Equity were among four firms bidding for the company. There have been similar reports in the press over the last month, particularly following purchases by Carl Icahn and others."
"Our view: while we cannot substantiate these reports, we do believe WebMD is a valuable asset that could be attractive to certain strategics as well as potential private equity."
"While recent news suggests a transaction could be in the works, we are maintaining our 2-Equal Weight rating given: 1) the lack of certainty of a deal, 2) our expectation that growth will remain challenged through 1H12, and 3) the lack of transparency surrounding the timing and extent of any fundamental turnaround in growth."
For an analyst ratings summary and ratings history on WebMD Health Corp. click here. For more ratings news on WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $37.75 yesterday.
Barclays analyst says, "What's new?: The New York Post reported yesterday (see 12/15/11 article, "Private Practice: WebMD close to sealing a deal with PE firms") that WebMD has put itself up for sale and that private equity firms KKR and Providence Equity were among four firms bidding for the company. There have been similar reports in the press over the last month, particularly following purchases by Carl Icahn and others."
"Our view: while we cannot substantiate these reports, we do believe WebMD is a valuable asset that could be attractive to certain strategics as well as potential private equity."
"While recent news suggests a transaction could be in the works, we are maintaining our 2-Equal Weight rating given: 1) the lack of certainty of a deal, 2) our expectation that growth will remain challenged through 1H12, and 3) the lack of transparency surrounding the timing and extent of any fundamental turnaround in growth."
For an analyst ratings summary and ratings history on WebMD Health Corp. click here. For more ratings news on WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $37.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BHP Group (BHP) Said to Weigh Potential Takeover of Anglo American (NGLOY) - Bloomberg
- IBM (IBM) Nears Acquisition of Software Provider HashiCorp (HCP) - WSJ
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
Create E-mail Alert Related Categories
Analyst Comments, Mergers and Acquisitions, Rumors, Trader TalkRelated Entities
Carl Icahn, Barclays, Providence Equity PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
